Упрощенная HTML-версия
M. G. Debalini, A. Rivetti // Cochrane Database Syst. Rev. - 2009. - № 1. -
Art. No.: CD000977.
344. Depression of the immune response to an inactivated hepatitis A vaccine
administered concomitantly with immune globulin / M. S. Green [et al.] // J. Infect.
Dis. - 1993. - Vol. 168. - P. 740-743.
345. Development and characterization of a severe acute respiratory syndrome-
associated coronavirus-neutralizing human monoclonal antibody that provides
effective immunoprophylaxis in mice / Т. C. Greenough [et alj // J. Infect.
D is.- 2 0 0 5 . -V o l. 191.-P . 507-514.
346. Development of a humanized monoclonal antibody with therapeutic potential
against West Nile virus / T. Oliphant [et al.] // Nat. Med. - 2005. - Vol. 11. -
P. 522-530.
347. The development of monoclonal human rabies virus-neutralizing antibodies as
a substitute for pooled human immune globulin in the prophylactic treatment
of rabies virus exposure / J. M. Champion [et al.]// J. Immunol. Methods. -
2000.-Vol. 235 .-P . 81-90.
348. Diamond, M. S. The Structural Immunology of Antibody Protection against West
Nile Virus / M. S. Diamond, Т. C. Pierson, D. H. Fremont // Immunol. Rev. -
2008 October. - Vol. 225. - P. 212-225.
349. Dimmock, N. J. Update on the neutralisation of animal viruses / N. J. Dimmock //
Rev. Med. Virol. - 1995. - №5. - P. 165-179.
350. Dumpis, U. Tick-borne encephalitis / U. Dumpis, D. Crook, J. Oksi // Clin. Infect.
Dis. - 1999. - Vol. 28,
4. - P. 882-890.
351. Early high-affinity neutralizing anti-viral IgG responses without further overall
improvements o f affinity / H. P. Roost [et al.] // Proc. Natl Acad. Sci. USA. -
1995. - Vol. 92. - P. 1257-1261.
352. Effect of passive antibody on the immune response of cotton rats to purified F
and G glycoproteins of respiratory syncytial virus (RSV) / B. R. Murphy [et al.] //
Vaccine.- 1 9 9 1 . -Vo l. 9 . -P . 185-189.
353. Effects o f Specific Antibodies against Streptococcus pneumoniae on
Pharmacodynamic Parameters of {beta}-Lactams in aMouse Sepsis Model/ J. Casal
[et al.] // Antimicrob. Agents Chemother. - 2002. - Vol. 46. - P. 1340-1344.
354. Effect on neutrophil kinetics and serum opsonic capacity of intravenous
administration of immune globulin to neonates with clinical signs of early-onset
sepsis / R. D. Christensen [et al.] // J. Pediatr. - 1991. - Vol. 118. - P. 606-614.
355. Efficacy of immune globulin in preventing complications of bone marrow
transplantation: a meta-analysis / E. B. Bass [et al.] // Bone Marrow Transplant. -
1993. - Vol. 12. - P. 273-282.
356. Efficacy of specific immunogiobulin against TBE (author’s transl) / C. Kunz [et al.] //
Wien Klin. Wochenschr. - 1981. - Vol. 93, № 21. - P. 665-667.
357. An efficient method to make human monoclonal antibodies from memory В cells:
potent neutralization of SARS coronavirus / E. Traggiai [et al.] // Nat. Med. -
2004. -Vol. 10. - P. 871-875.
358. Enzyme-linked immunosorbent assay for detection of hepatitisA antigen in stool and
antibody tohepatitisAantigen insera: comparisonwithsolid-phase radioimmunoassay,
immune electron microscopy andimmune adherence haemagglutination assay/
L. R. Mathiesen [et al.] // J. Clin. Microbiol. - 1978. - Vol. 7, № 2. - P. 184-193.
222